At the recent International Society for Heart and Lung Transplantation (ISHLT) meeting, Dr. Eileen Hsich from the Cleveland Clinic shared a transformative idea for heart transplant allocation. She urged a shift from national systems to a more global approach to tackle inequalities in organ distribution.
Dr. Hsich highlighted a stark reality: the gap between patients needing heart transplants and the number of available organs is growing. “To cut down waitlist deaths and promote equity, we must rethink how we share donor hearts worldwide,” she stated.
Recent data from ISHLT shows significant inequalities in access to transplants. Lower-income patients are facing higher mortality rates while waiting for a heart. “It’s about more than just equal access; it’s about making sure help goes where it’s really needed,” she explained.
Interestingly, wealthier nations perform many more heart transplants than poorer ones, even when the demand is similar. Canada serves as a model, showing a good link between transplant rates and needs.
Dr. Hsich also mentioned innovative tools like the Donor Utilization Score (DUS), which can help identify suitable donor hearts. “We have the means to better evaluate heart quality, now we need to maximize the use of viable organs,” she noted.
Innovations in organ preservation are changing the game. Techniques like normothermic machine perfusion allow donor hearts to stay viable longer, even for international transport. A recent case showed a heart successfully moved from the West Indies to Paris. The recipient, a 70-year-old, recovered well and was discharged in under a month. “This is now a reality. The real question is are we ready to expand this approach?” Dr. Hsich said.
A global heart transplant system isn’t just a dream. Successful cross-border initiatives, like the DKMS’s work in bone marrow transplants, suggest it can be done. However, challenges remain. For a global system to work, we need international cooperation, solid funding, and clear ethical guidelines.
Dr. Hsich pointed out, “Globalization comes with ethical responsibilities. We must ensure any system promotes fairness and maintains high quality for patients everywhere.”
With its extensive network and expertise, ISHLT could lead the charge for this global system. “If we collaborate effectively, we can reduce disparities and ensure no viable donor heart goes to waste,” she concluded.
For more on this topic, check out the International Society for Heart and Lung Transplantation.
Source link
Heart, Transplant, Heart Transplantation, Lung Disease, Medicine
